News & Updates

Faropenem, when used in combination with the other standard treatment drugs for the first-line treatment of tuberculosis (TB) infection, appears to be noninferior to ethambutol, with faropenem having the added benefit of lower frequency of adverse events (AEs), according to the results of an open-label study in China.

The baseline skin cytokine profile of patients with eczematous dermatitis, as determined by RNA in situ hybridization, can help predict response to dupilumab therapy, results of a study have shown.

COVID-19 remains a global health concern, and children and adolescents are equally affected. In fact, COVID-19 hospitalization rates in children increased during the Omicron era. [MMWR 2022;71:271-278] In children aged 5–11 years who were hospitalized during the predominance of Omicron, nearly 90 percent were unvaccinated. [MMWR 2022;71:574-581]

An intermittent calorie-restricted diet is effective at achieving diabetes remission for at least a year, a recent study has shown.

Increased levels of urinary nitrate appear to contribute to a reduction in the risk of congestive heart failure and diabetic retinopathy and may also lower the risk of death from all causes, cardiovascular disease (CVD), and diabetes in adults with hyperglycaemia, suggests a study.